SYS-CON MEDIA Authors: Jason Bloomberg, Kevin Benedict, David H Deans, RealWire News Distribution, Gilad Parann-Nissany

News Feed Item

These Stocks, CIEN, CXO, R and ENDP, Have Recently Been Rated

LONDON -- (Marketwire) -- 12/17/12 -- Wall Street Active pro-traders will be assisting investors today on CIEN, CXO, R and ENDP, and provide insight based on their extensive experience so that you can boost your stock portfolio on the short-term or the long-term. If you are a shareholder in any of these companies do not miss this once in a life time opportunity, as our trading experts can show how to turn $5,000 into $35,000.

Ciena Corporation (NASDAQ: CIEN) closed at $15.71 on Friday. CIEN was downgraded recently by Barclays. Speak with our pros today and see if they agree with this new rating for CIEN. Sign up now at

http://www.wallstreetactive.com/register.php

Concho Resources Inc. (NYSE: CXO) closed at $82.39 on Friday. CXO was upgraded recently by RBC Capital Mkts. Speak with our pros today and see if they agree with this new rating for CXO. Sign up now at

http://www.wallstreetactive.com/register.php

Ryder System Inc. (NYSE: R) closed at $49.60 on Friday. R was upgraded recently by RBC Capital Mkts. Speak with our pros today and see if they agree with this new rating for R. Sign up now at

http://www.wallstreetactive.com/register.php

Endo Health Solutions Inc. (NASDAQ: ENDP) closed at $25.62 on Friday. ENDP was downgraded recently by Needham. Speak with our pros today and see if they agree with this new rating for ENDP Sign up now at

http://www.wallstreetactive.com/register.php

Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.